Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version




Profile of registrant

Pfizer Inc.

Identification number in the register: 4263301811-33
Registration date: 18/12/08 10:25:52

The information on this organisation was last modified on 21/11/14 16:40:57
The date of the last annual update was 21/11/14 16:27:28


Registrant : Organisation or self-employed individual

Name/company name: Pfizer Inc.
Acronym: PFE
Legal status: Corporation
Website address: http://www.pfizer.com

Sections

Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  Ian C. Read
Position: CEO

Permanent person in charge of EU relations

Surname, Name: Mrs  Eva Grut-Aandahl
Position: Head of EU Office

Contact details:

Contact details of organisation's head office: 235 East 42nd Street 
New York NY 10017
UNITED STATES
Telephone number: (+1) 2127332323
Fax number: (+) 
Other contact information: Contact details of Brussels office:

Pfizer European Government Affairs
Boulevard de la Plaine/Pleinlaan 17,
B-1050 Brussels

Tel: +32 2 554 62 11
Fax: +32 2 554 66 60

Goals / remit

Goals / remit of the organisation: At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In 2012, Pfizer's revenue was 59bn, with approx. 4.5 bn invested in research and development.To learn more, please visit us at www.pfizer.com.
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 5
Complementary information: 5 colleagues are full-time engaged in the Brussels office and will spend between 75%-100% of their time on EU affairs. The number below also include others (16) who may only spend a fraction of their time (between 1.5%-10%)

Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Matthew Thomas CLAY 16/01/14 10/01/15

Activities

Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:


Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Competition
  • Consumer Affairs
  • Customs
  • Economic and Financial Affairs
  • Enlargement
  • Enterprise
  • Environment
  • External Relations
  • General and Institutional Affairs
  • Humanitarian Aid
  • Internal Market
  • Justice and Fundamental Rights
  • Public Health
  • Research and Technology
  • Trade

Networking

Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.




Pfizer is a member of: EFPIA, EBE, Vaccines Europe, EuropaBio, AESGP, Amcham EU, BusinessEurope, TPN, TABC

Financial data

Financial year: 11/2013 - 11/2014
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 700000  € - 800000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:

This estimate is based on the pro rata salary costs of Pfizer staff involved in interest representation to the European institutions, based on the proportion of employee time spent on these activities. A proportion of overheads for our Brussels office is included in the estimate on the same basis. Membership fees and payments to third parties are not included to avoid double counting.

Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.

The organisation has also declared to be bound to the following other Code:
Internal Pfizer FCPA Code and Compliance, EFPIA Codes